ScreenHER

Why the most important breakthroughs often fail to reach the people who need them most.

“Ideas are easy. Implementation is hard.”

Guy Kawasaki

Every year, researchers around the world make discoveries with the potential to improve millions of lives. New biomarkers are identified. New therapies are explored. New technologies emerge that may help us detect disease earlier, treat it more effectively, or make healthcare more accessible.

Yet most of those discoveries never become products.

Not because the science was wrong. Not because the idea lacked potential. More often, the discovery simply never made the long and difficult journey from the laboratory to the people it was meant to help.

Great Discoveries Happen Every Day

Scientific discovery is one of humanity’s greatest achievements. Universities, research institutions, and laboratories are constantly expanding what we know about the world and uncovering new possibilities for the future.

But discovery is only the beginning of the story.

A biomarker identified in a research paper cannot help a patient on its own. A promising technology sitting in a laboratory does not improve healthcare outcomes. For science to create impact, it must leave the laboratory and enter the real world.

That journey is often far more difficult than the discovery itself.

The Post-it Note Wasn’t an Accident

One of the simplest examples comes from a product most of us use without thinking about it.

In the 1960s, a scientist at 3M developed a weak adhesive. The glue worked, but not in the way anyone expected. It was sticky enough to attach to paper, but weak enough to remove without causing damage. At first, the invention appeared to have little practical value.

Years later, another employee realized the adhesive could be used to keep bookmarks in place. That simple insight eventually led to the Post-it Note.

The breakthrough was not the adhesive alone. The breakthrough was figuring out how to transform that adhesive into a product people would use every day.

The discovery mattered.

The product changed the world.

The Hard Part Comes After the Discovery

Many promising healthcare technologies never make it beyond this point.

Moving from discovery to product requires a completely different set of skills and resources. It requires engineers, product developers, manufacturers, regulatory experts, clinicians, investors, and operators. It requires years of testing, iteration, problem-solving, and persistence.

In healthcare, the challenge can be even greater. A promising signal may be identified in a laboratory and supported by compelling data, yet patients still cannot benefit until someone figures out how to make it reliable, affordable, scalable, manufacturable, and accessible.

The hard part is often not discovering something new.

The hard part is making it useful.

We Celebrate Discovery. We Underestimate Translation.

Scientific breakthroughs often make headlines. The years of work required to transform those discoveries into products rarely do.

Yet that is where much of the impact is created.

Patients do not benefit from a promising research paper. They benefit when a discovery becomes something that can be manufactured, distributed, used, trusted, and integrated into everyday care. The process of translation rarely receives the same attention as the initial breakthrough, but it is what ultimately determines whether a discovery reaches the people who need it.

Translation is where possibility becomes impact.

Why So Many Good Ideas Stall

Every year, promising healthcare technologies are left behind.

Some run out of research funding. Some lack a clear regulatory path. Some are too expensive to manufacture. Others never find the right team to carry them forward. In many cases, the science is not the problem.

The challenge is building the bridge between discovery and deployment.

That bridge requires funding, product development, manufacturing, testing, regulatory planning, and years of focused execution. It requires people willing to take ownership of the long middle chapter between invention and adoption.

This is one reason why some of the most important work in healthcare happens after the initial breakthrough.

Building the Bridge

At ScreenHER, we believe some of the most important opportunities in healthcare exist in the gap between discovery and deployment.

Over the past year, I have spent more time thinking about translation than discovery. My background is in mechanical engineering, but much of my career has focused on commercial strategy: understanding how complex science becomes a product clinicians prefer, patients understand, partners support, and markets adopt.

Throughout my career in medtech, I have seen remarkable technologies struggle to gain traction—not because they lacked scientific merit, but because the path from laboratory to real-world adoption is long, complex, and often underappreciated. Scientific discovery and commercial success are related, but they are not the same thing.

That is the work ScreenHER is taking on.

Our focus is on taking promising scientific advances and transforming them into practical tools designed to help more women access earlier cancer detection. While scientific discovery is essential, we believe real impact occurs when those discoveries become products that fit into people’s lives, healthcare systems, and everyday clinical workflows.

The journey from breakthrough to product is rarely simple. It requires persistence, collaboration, technical expertise, commercial discipline, and a willingness to solve problems that extend far beyond the laboratory. It is often slower, harder, and less visible than the discovery itself.

But that work matters.

Because discoveries do not change lives on their own.

Products do.

If you share our passion for expanding access to early cancer detection, women’s health innovation, or point-of-care diagnostics, we’d love to connect.

---

About the Author